ARTICLE | Company News
Action Pharma, Zealand Pharma, Abbott deal
June 25, 2012 7:00 AM UTC
Abbott completed the acquisition of AP214 and related IP from Action following the receipt of U.S. Antitrust clearance. Last year, the alpha-melanocyte-stimulating hormone analog met the primary endp...